| |
|
|
|
Vbi Vaccines Inc CS  
|
|
3.41 0.51 (0.18%) |
11-30 15:15 |
|
Open: |
2.96 |
Pre close: |
2.9 |
Target:
|
4.12 
|
|
High: |
3.53 |
Low: |
2.95 |
Resistance:
|
3.53
4.12
|
|
Volume: |
18,837,698 |
Market Cap: |
825M |
Support:
|
2.63
2.07
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.85
|
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
2.60 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
3.41  |
Stochastic Oscillator |
%K(14,3):
|
82.53 |
|
MA(250): |
2.30 |
%D(3): |
69.95 |
|
Average Volume(K) |
3-Month: |
640622
|
52-Week |
High:
|
6.93 |
|
10-Days: |
743362 |
Low: |
0.69 |
|
RSI |
RSI(14):
|
66.87 |
Change(%): |
293.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.206 |
Return on Equity (ttm) |
-31.7 |
Shares Out. (M) |
231.20 |
|
EPS Est. Current Year |
-0.890 |
Return on Assets (ttm) |
-14.9 |
Shares Float (M) |
161.74 |
|
EPS Est. Next Year |
-1.010 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.52 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
-53.9 |
% Held by Institutions |
53.41 |
|
Forward EPS |
-0.460 |
Gross Profit (p.s.) |
-0.025 |
Shares Short (K) |
42650 |
|
Book Value (p.s.) |
0.690 |
EBITDA (p.s.) |
-0.164 |
P/E |
-16.53 |
|
Sales Per Share |
0.006 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.93 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-39.09 |
P/S |
535.53 |
|
Operating Margin |
-2690.21 |
Levered Free Cash Flow
(M) |
-23.69 |
P/CF |
-20.14 |
|
|
|
|
|
|
